Healthy AgingNCT04279366
Biological Age Applied at Ubberup
An observational study of Healthy Aging and Lifestyle Risk Reduction, run by University of Copenhagen at 2 sites in Denmark.
Trial summary
In a previous study the investigators have developed a novel biological age model. Assessing biological age is the assessment of the present health status and functional capacity/physiological reserve of that person in comparison with people of the same age and sex. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy Aging, Lifestyle Risk Reduction
- What is being tested?
- Lifestyle intervention
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 83 participants
- Where
- 2 sitesDenmark
- Study dates
- 15 Nov 2020to 6 Jun 2022
- How long will I take part?
- 14 Weeks
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: adults participating and finishing the 12-14 week intensive lifestyle intervention at Ubberup folk high school.
Who may be able to join
- Participation in a long course at Ubberup folk high school (12-15 weeks)
- Age between 18-65 years
Who cannot join
- Previous or current cardiovascular disease
- Pregnancy
- Conditions that prevents from performing a cycle and/or strength tests
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites
Xlab, Faculty of Health and Medical Sciences, University of Copenhagen
Copenhagen, 2200
Ubberup High School
Kalundborg, Danmark, 4400
About this study
Official title: Evaluation and Validation of Biological Age as Health Technology
In a previous study the investigators have developed a novel biological age model. Assessing biological age is the assessment of the present health status and functional capacity/physiological reserve of that person in comparison with people of the same age and sex.
The aim of this study is to investigate the utility and validity of this novel biological age model designed for health promotion in real world conditions.
Read the detailed description
Study design: This is a longitudinal study, where biological age assessment is conducted in the first and final week of an 11-14 week lifestyle intervention course. These courses take place at a Danish folk high school (Ubberup), which is specialized in performing intensive lifestyle interventions targeting a 10% weight loss. The intention is to include 80 adult men and women.
Data collection: This will take place at the facilities at Ubberup folk high school, participants being overnight fasted and without having exercised for the previous 24 hours. All analysis will be performed in investigators lab (Xlab) at the Department of Biomedical Sciences, Copenhagen University. When all samples are analysed Biological age will be calculated for each particpant.
- Conditions
- Healthy Aging, Lifestyle Risk Reduction
- Being tested
- Lifestyle intervention
- Keywords
- Individualised Health, Prediction, Risk Assessment
- Medical subject headings
- Risk Reduction Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lifestyle interventionBehavioural
The 14 week courses takes place at a Danish folk high school (Ubberup), specialized in lifestyle interventions targeting a 10% weight loss. Adult individuals with obesity sign up for the course. They stay at the School for the whole course period and the total cost amounts to 300-400 Euros per week plus loss of income.
| Study group | Role | What they receive |
|---|---|---|
| Winter course | The recruited particpants attending the winter course Receives: Behavioral: Lifestyle intervention | |
| Fall course | The recruited particpants attending the winter course Receives: Behavioral: Lifestyle intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in biological age
a composite score predicting risk of lifestyle related diseases
Measured: week1 and week 14
Secondary outcomes (16)
Change in cardiorespiratory capacity
VO2max maximal oxygen consumption (ml/min/kg
Measured: week 1 and week 14
Change in strength
Hand grip, isometric quadriceps and biceps strength (Nm)
Measured: week 1 and week 14
Change in Sit to Stand test
Rise and sit from a chair as many times as possible during 1 minute (number og rises)
Measured: week 1 and week 14
Change in Central obesity
Waist to hip ratio is measured by dividing waist circumference with hip circumference in cm.
Measured: week 1 and week 14
Change in body weight
measured in kilograms
Measured: week 1 and week 14
Change in body composition
BMI (kg/m2) is calculated
Measured: week 1 and week 14
Change in fat mass
fat mass(g) is assessed by bioimpedance
Measured: week 1 and week 14
Change in fat percentage
Fat%, is assessed by bioimpedance
Measured: week 1 and week 14
Change in muscle mass
muscle mass(g) is assessed by bioimpedance
Measured: week 1 and week 14
Change in lipid profile
HighDensityLipoprotein (mmol/L), LowDensityLipoprofile (mmol/L), TriGlycerides (mmol/L), FreeFattyAcids (mmol/L) and Glycerol (mmol/L) is measured in a blood sample.
Measured: week 1 and week 14
Change in Inflammatory profile
C-reactive protein mg/L, soluble urokinase plasminogen activating receptor ng/ml, InterLeukin 6 and 8 (pg/mL), tumor necrosis factor (pg/mL), Leptin and Adiponectin (ng/ml) is analysed from blood samples
Measured: week 1 and week 14
Change in Blood glucose
HbA1c and fasting glucose (mmol/L) measured from blood sample
Measured: week 1 and week 14
Change in Respirometry
forced vital capacity and forced expiratory volume at one second(L)
Measured: week 1 and week 14
Change in Blood Pressure
Systolic and Diastolic blood pressure (mmHg)
Measured: week 1 and week 14
Change in Advanced glycation endproducts
Levels of glycated protein and lipids as a result of exposure of excess sugars advanced glycation endproducts (AGE) measured in the skin
Measured: week 1 and week 14
Change in Hormones
Insulin
Measured: Week 1 and week 14
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Feb 2020
- Study start15 Nov 2020
- Primary completion6 Jun 2022
- Study completion6 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Healthy AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 83 participants (actual)
- Target duration
- 14 Weeks
Sponsor and investigators
- Lead sponsor
- University of Copenhagen
- Sponsor type
- University, hospital or other
- Collaborators
- Technical University of Denmark
- Responsible party
- Principal investigator, Jørn Wulff Helge, University of Copenhagen
- Investigators
- Jørn W Helge, PhD, Principal investigator, University of Copenhagen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04279366
- Sponsor's protocol ID
- UbberupBioAge
- Status last verified
- Feb 2024
- First submitted
- 18 Feb 2020
- Last updated
- 15 Feb 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Hansen MT, Husted K, Modvig JL, Lange KK, Weinreich CM, Tranberg C, Romer T, Ingersen A, Dela F, Helge JW. V̇O2peak estimation in people with overweight and obesity before and after a 14-week lifestyle intervention. Int J Obes (Lond). 2025 May;49(5):864-871. doi: 10.1038/s41366-025-01713-9. Epub 2025 Jan 20.
PubMed 39833426Husted KLS, Fogelstrom M, Hulst P, Brink-Kjaer A, Henneberg KA, Sorensen HBD, Dela F, Helge JW. A Biological Age Model Designed for Health Promotion Interventions: Protocol for an Interdisciplinary Study for Model Development. JMIR Res Protoc. 2020 Oct 26;9(10):e19209. doi: 10.2196/19209.
PubMed 33104001
Study at a glance
From the registry record, last updated by the sponsor on 15 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation and Validation of Biological Age as Health Technology
- ClinicalTrials.gov ID
- NCT04279366
- Acronym / sponsor ID
- UbberupBioAge
- Conditions
- Healthy Aging, Lifestyle Risk Reduction
- Keywords
- Individualised Health, Prediction, Risk Assessment
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 83 participants (actual)
- Lead sponsor
- University of CopenhagenUniversity, hospital or other
- Collaborators
- Technical University of Denmark
- Study start
- 15 Nov 2020 (actual)
- Primary completion
- 6 Jun 2022 (actual)
- Study completion
- 6 Jun 2022 (actual)
- First posted
- 21 Feb 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In a previous study the investigators have developed a novel biological age model. Assessing biological age is the assessment of the present health status and functional capacity/physiological reserve of that person in comparison with people of the same age and sex.
The aim of this study is to investigate the utility and validity of this novel biological age model designed for health promotion in real world conditions.
Detailed description
Study design: This is a longitudinal study, where biological age assessment is conducted in the first and final week of an 11-14 week lifestyle intervention course. These courses take place at a Danish folk high school (Ubberup), which is specialized in performing intensive lifestyle interventions targeting a 10% weight loss. The intention is to include 80 adult men and women.
Data collection: This will take place at the facilities at Ubberup folk high school, participants being overnight fasted and without having exercised for the previous 24 hours. All analysis will be performed in investigators lab (Xlab) at the Department of Biomedical Sciences, Copenhagen University. When all samples are analysed Biological age will be calculated for each particpant.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 14 Weeks
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Winter course | – | Behavioral: Lifestyle interventionThe recruited particpants attending the winter course |
| Fall course | – | Behavioral: Lifestyle interventionThe recruited particpants attending the winter course |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- adults participating and finishing the 12-14 week intensive lifestyle intervention at Ubberup folk high school.
Key inclusion criteria (2 listed)
- Participation in a long course at Ubberup folk high school (12-15 weeks)
- Age between 18-65 years
Key exclusion criteria (3 listed)
- Previous or current cardiovascular disease
- Pregnancy
- Conditions that prevents from performing a cycle and/or strength tests
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lifestyle interventionThe 14 week courses takes place at a Danish folk high school (Ubberup), specialized in lifestyle interventions targeting a 10% weight loss. Adult individuals with obesity sign up for the course. They stay at the School for the whole course period and the total cost amounts to 300-400 Euros per week plus loss of income. | Behavioural | Fall course, Winter course |
Primary outcome
Change in biological age
Time frame: week1 and week 14
a composite score predicting risk of lifestyle related diseases
16 secondary outcomes
Change in cardiorespiratory capacity
Time frame: week 1 and week 14
Change in strength
Time frame: week 1 and week 14
Change in Sit to Stand test
Time frame: week 1 and week 14
Change in Central obesity
Time frame: week 1 and week 14
Change in body weight
Time frame: week 1 and week 14
Change in body composition
Time frame: week 1 and week 14
Change in fat mass
Time frame: week 1 and week 14
Change in fat percentage
Time frame: week 1 and week 14
Change in muscle mass
Time frame: week 1 and week 14
Change in lipid profile
Time frame: week 1 and week 14
Change in Inflammatory profile
Time frame: week 1 and week 14
Change in Blood glucose
Time frame: week 1 and week 14
Change in Respirometry
Time frame: week 1 and week 14
Change in Blood Pressure
Time frame: week 1 and week 14
Change in Advanced glycation endproducts
Time frame: week 1 and week 14
Change in Hormones
Time frame: Week 1 and week 14
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Feb 2024.
- Derived from this study: PubMed 39833426Hansen MT, Husted K, Modvig JL, Lange KK, Weinreich CM, Tranberg C, Romer T, Ingersen A, Dela F, Helge JW. V̇O2peak estimation in people with overweight and obesity before and after a 14-week lifestyle intervention. Int J Obes (Lond). 2025 May;49(5):864-871. doi: 10.1038/s41366-025-01713-9. Epub 2025 Jan 20.
- Derived from this study: PubMed 33104001Husted KLS, Fogelstrom M, Hulst P, Brink-Kjaer A, Henneberg KA, Sorensen HBD, Dela F, Helge JW. A Biological Age Model Designed for Health Promotion Interventions: Protocol for an Interdisciplinary Study for Model Development. JMIR Res Protoc. 2020 Oct 26;9(10):e19209. doi: 10.2196/19209.
- Individual participant dataSharing planned: Undecided
Related trials for Healthy Aging
RecruitingObservational study
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
Healthy Volunteers, Non-Healthy/Non-Frail
Not yet recruitingObservational study
China Healthy Aging and Fitness Longitudinal Study
Physical Fitness, Aging
Not yet recruiting
Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older Adults
Dehydrated, Water-Electrolyte Imbalance, Malnutrition, Dehydration (Physiology)
Not yet recruiting
Effects of Probiotics on Skin Health in Healthy Women
Skin Aging, Dry Skin
Active, not recruiting
Improving Medication Management in World Trade Center Responders
Polypharmacy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jørn W Helge, PhD principal investigator
University of Copenhagen
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy Aging and Lifestyle Risk Reduction, run by University of Copenhagen at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in biological age (time frame: week1 and week 14). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04279366, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2024.